Drug Safety Pharmacovigilance
1. Patient 2. Event 3. Reporter
Patient Initials*
Age / Date of Birth*
Gender* SelectMaleFemaleOther
Product Name*
Batch / Lot Number
Event Start Date*
Description of Symptoms*
Reporter Name*
Phone Number*
Email Address*
I consent to the processing of personal data and agree with the user agreement and privacy policy
Showing the single result
Therapeutic Segment: Anti-fibrinolytic Generic Name: Tranexamic Acid Available as: Capsule 250 mg Capsule 500 mg Injection 250mg/5ml Injection 500mg/5ml Prescribing